
    
      This study aims to determine the effect of probiotics, as the investigational products (IPs)
      in subjects satisfying the Rome IV criteria for IBS. Three hundred and sixty six subjects
      between 18 to 70 years of age and with a positive diagnosis of Rome IV IBS criteria (IBS-C,
      D, M and U types) and moderate to severe abdominal pain intensity will be recruited in a
      multi-center, double-blind, parallel group, placebo-controlled randomized trial.
    
  